chronic liver disease
FDA Approves Mulpleta for Thrombocytopenia in Adults With Chronic Liver Disease
The FDA approved lusutrombopag for thrombocytopenia in adults with chronic liver disease who are scheduled to ...
JULY 31, 2018
FDA Approves Doptelet for Certain Liver Patients
The FDAapproved Doptelet to treat thrombocytopenia in adults with chronic liver disease who are scheduled to ...
MAY 21, 2018
Load more